Home
About
Overview
Sharing Data
ORCID
Help
History (52)
Case for Earlier Surgical Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.
Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence.
Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria.
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.
Hypertrophic Cardiomyopathy: Is a 'Cure' Coming . . . Or Is It Already Here?
See All 52 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Hypertrophic Cardiomyopathy: Is a 'Cure' Coming . . . Or Is It Already Here?
Maron BJ, Rowin EJ, Maron MS. Hypertrophic Cardiomyopathy: Is a 'Cure' Coming . . . Or Is It Already Here? Am J Med. 2020 08; 133(8):886-888.
View in:
PubMed
subject areas
Anti-Arrhythmia Agents
Anticoagulants
Atrial Fibrillation
Cardiomyopathy, Hypertrophic
Catheter Ablation
Death, Sudden, Cardiac
Defibrillators, Implantable
Heart Failure
Humans
Ventricular Outflow Obstruction
authors with profiles
Martin S Maron MD, MSPH
Barry J Maron MD
Ethan Rowin MD, MBA